Back to mobile site

More on NRXP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NRx Pharmaceuticals (NQ:NRXP)
Delayed: 3.29 -0.03 (0.9%)
Prev. Close $3.32  
Open$3.37 
52 Wk High$ 
52 Wk Low$ 
Day High$3.39 
Day Low$3.29 
P/E N/A  
EPS$ 
Volume379,982 

Friends, Peers and Foes (?): DVLT, RDZN, MDCX, VTIX, SNYR (more...)

Sep 16, 2026 06:02 AM Form 8-K NRX Pharmaceuticals, For: Sep 15
Sep 15, 2026 03:11 PM FDA reclassifies NRx Pharmaceuticals ketamine application amendment
Sep 15, 2026 03:11 PM NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
Sep 14, 2026 08:00 AM Form 8-K NRX Pharmaceuticals, For: Sep 08
Sep 14, 2026 07:19 AM GeNeuro wins European patent for ALS drug candidate GNK-301
Sep 14, 2026 07:00 AM GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
Sep 11, 2026 07:00 AM NRx subsidiary HOPE begins training on FDA-cleared robotic TMS system
Sep 11, 2026 07:00 AM NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
Sep 11, 2026 07:00 AM NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
Sep 8, 2026 07:00 AM NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
View All Articles

Entities mentioned with NRXP

View All Entities